MedImmune confirms $6.5 million research deal with Johns Hopkins

12/13/2013 | Genetic Engineering & Biotechnology News

Johns Hopkins University has signed a deal with AstraZeneca's research and development arm MedImmune to collaborate on research projects in cancer; respiratory conditions, inflammation and autoimmunity; infectious disease; antibody development and protein engineering.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park